3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMGCR or HMG-CoA REDUCTASE) - ANVISA Registration 80003610614
Access comprehensive regulatory information for 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMGCR or HMG-CoA REDUCTASE) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80003610614 and manufactured by INOVA DIAGNOSTICS, INC. The registration is held by WERFEN MEDICAL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 1 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED, and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80003610614
25351462167202497
02004662000165
Company Information
Dates and Status
Feb 17, 2025
VIGENTE
09/18/2025 19:00:01

